skip navigation

Center for Infectious Disease Research

  • HOME
  • R&D
  • Center for Infectious Disease Research

Center for Infectious Disease Research

Center Overview

The Infectious Disease Research Center is conducting studies on the development and commercialization of key technologies, such as for blocking the spread of antimicrobial resistance, eradicating tuberculosis, and responding to bacterial zoonoses caused by climate change, in order to create public value to overcome bacterial infectious diseases that threaten citizens’ safety. While strengthening infrastructure to activate domestic research, the center is establishing itself as a backbone of bacterial infectious disease research by expanding and supporting international research cooperation.

Center for Infectious Disease Research
  • Division of Bacterial Disease Research
  • Division of Zoonotic and Vector Borne Disease Research
  • Division of Antimicrobial Resistance Research

Organization

Research on bacterial diseases, zoonoses, and antimicrobial resistance

Vision System

Vision
To alleviate the burden caused by diseases by developing bacterial infectious disease early diagnosis and treatment technologies

through research to overcome and control antimicrobial resistance as well as acute and chronic bacterial infections, such as tuberculosis, and bacterial zoonoses

Strategic Direction
Strengthen study to reduce the control and treatment period

Diversify the development of new diagnostic and treatment methods and therapeutics, and strengthen the scientific grounds for technology development

Strengthen clinical transitional and cooperative research

Expand One Health cooperative research in Korea and abroad, and strengthen the function as a bridgehead for industry - academe - research - hospital cooperation

Strengthen the public base

Strengthen the platform base, such as for accumulation and use of bio information and research base

Key Tasks
1

Leading studies on the controlling antimicrobial resistant bacteria for the national antimicrobial resistance mangement

  • 1-1. Develop early control and diagnosis technologies for antimicrobial resistance
  • 1-2. Conduct studies to expand multidrug-resistant bacteria treatment options based on new technologies
  • 1-3. Operate infrastructure for integrated resistant bacteria monitoring and research from the One Health perspective
2

Conduct advanced R&D for bacterial infectious diseases centering on solution and application

  • 2-1. Strengthen role as a control tower for tuberculosis research
  • 2-2. Promote preemptive problem solving-type commercialization study by reflecting policy demand
  • 2-3. Expand bases for research on bacterial infectious diseases and domestic and international research cooperation
3

Conduct R&D in response to bacterial zoonoses and vector-borne diseases

  • 3-1. Plan cooperative research for bacterial zoonoses and vector-borne diseases
  • 3-2. Develop technologies for responses to bacterial zoonoses and vector-borne diseases
  • 3-3. Develop technologies to analyze biological information of infectious disease pathogens

Division of Bacterial Disease Research

Functions
  • Conduct studies on bacterial intestinal infections
  • Conduct studies on sexually transmitted bacteria
  • Conduct studies on toxinogenic bacterial diseases
  • Conduct studies on mycobacterium tuberculosis complex and respiratory infection bacterial diseases
  • Conduct studies on high-risk bacterial pathogens
  • Conduct studies on diagnostic agents and therapeutics related to the above
  • Handle other matters that do not fall under the responsibility of other departments
Goals
  • To conduct study for next-generation tuberculosis diagnosis and treatment technology development
  • To conduct study for unresolved and intractable bacterial infection response and control technology development
  • To conduct study for the infrastructure, support, and development of bacterial infectious disease study activation
Research Conducted
  • Development of key diagnostic and therapeutic technologies for the eradication of tuberculosis by 2030
  • Development of troubleshooting-type leading technologies for unresolved and intractable bacterial infections
  • Activation of and increased support for studies on bacterial infections in Korea and abroad

Division of Zoonotic and Vector Borne Disease Research

Functions
  • Conduct studies on zoonoses and rickettsial infections
  • Conduct studies on vector-borne bacterial diseases
  • Conduct studies on prion diseases
  • Conduct studies on tropical endemic and chronic indigenous parasitic diseases, and protozoal diseases
  • Conduct studies on the collection, analysis, production, and management of bioinformation on pathogens
  • Conduct studies on diagnostic agents and therapeutics related to above
Goals
  • To develop technologies for response to zoonoses and vector-borne bacterial diseases
  • To develop a joint response network for One Health-level infectious disease spread blocking
  • To establish infrastructure by strengthening inter-ministerial joint research capabilities for vector-borne bacterial diseases and zoonoses
  • To develop the human microbiome-based research platform and candidates for Korean targeted therapy by promoting national projects for linkage to hospitals and clinical application with the goal of overcoming intractable infectious diseases
Research Conducted
  • Development of technologies for response to zoonoses and vector-borne diseases
  • Establishment of cooperative research system for zoonoses and strengthening of the research infrastructure
    • - Strengthen joint research capabilities among ministries
    • - Strengthen international cooperation
  • Study on the collection, analysis, production, and management of bioinformation on pathogens, such as microbiome
    • - Establish hospital-based longitudinal research cohorts to secure disease-customized clinical information and samples
    • - Establish a system for linkage to the collection and analysis protocol standardization and quality management center
    • - Develop potential emerging and variant infectious disease prediction model based on microbiome
    • - Development of microbiome therapeutics and technologies based on meta data for the treatment of intractable infectious diseases

Division of Antimicrobial Resistance Research

Functions
  • Research on antimicrobial resistance
  • Research on healthcare-associated infectious pathogens
  • Research on fungal infections
  • Research on antifungal resistance
  • Research on the development of antibiotic agents
  • Research on diagnostics and therapeutics related to antimicrobial-resistant bacteria
Goals
  • To develop tracking, diagnostic, and treatment technologies for antimicrobial-resistant bacteria control in multi-sectors
  • To conduct therapeutics development and clinical study to expand treatment option for multidrug-resistant bacteria
  • To provide research infrastructure for activating antimicrobial resistance researches and integrated surveillance of antimicrobial-resistant bacteria
Research Conducted
  • Operating of National Reference Lab with a Korean global antimicrobial resistance surveillance system (Kor-GLASS)
  • Study for the integrated monitoring and spread of antimicrobial-resistant bacteria in multiple fields from the One Health perspective
  • Study on the development of point of care diagnostics for antimicrobial-resistant bacteria
  • Study on the development of new therapeutics for antimicrobial-resistant bacteria
  • International cooperation including the operation of the WHO collaborating center